Search research articles
Contact Us
Filters
Showing results (21-30 of 216) with videos related to
Page
of 22
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 12, 2012
Caffeine occupancy of human cerebral A1 adenosine receptors: in vivo quantification with 18F-CPFPX and PET
David Elmenhorst, Philipp T Meyer, Andreas Matusch, et al.
Nuklearmedizin. Nuclear Medicine
|
April 15, 2025
The Status of Neuroimaging with SPECT and PET in Germany: Results from the 1st Survey on Nuclear Neuroimaging in Germany in 2023
Ralph Buchert, Alexander Drzezga, Mathias Schreckenberger, et al.
Clinical Nuclear Medicine
|
May 27, 2022
Diffuse Bone Marrow Involvement of Multiple Myeloma on [ 18 F]PSMA-1007 PET/CT : Is There a Theranostic Potential?
Kerstin Michalski, Cordula A Jilg, Monika Engelhardt, et al.
Journal of Alzheimer'S Disease : JAD
|
May 17, 2021
DAT SPECT Predicts Survival in Patients Assessed for Differential Diagnosis of Dementia
Lars Frings, Franziska Henninger, Martin Treppner, et al.
Alzheimer'S Research & Therapy
|
January 10, 2023
More extensive hypometabolism and higher mortality risk in patients with right- than left-predominant neurodegeneration of the anterior temporal lobe
Lars Frings, Ganna Blazhenets, Raphael Binder, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 11, 2018
Amyloid imaging for differential diagnosis of dementia: incremental value compared to clinical diagnosis and [<sup>18</sup>F]FDG PET
Sabine Hellwig, Lars Frings, Tobias Bormann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 30, 2024
Reliable diagnosis of nigrostriatal degeneration by dopamine transporter SPECT despite drug interaction with venlafaxine or bupropion
Ivayla Apostolova, Sabine Hellwig, Amir Karimzadeh, et al.
Scientific Reports
|
August 28, 2024
Deformation-based morphometry applied to FDG PET data reveals hippocampal atrophy in Alzheimer's disease
Lars Frings, Ganna Blazhenets, Joachim Brumberg, et al.
Clinical Nuclear Medicine
|
December 27, 2019
Nigrostriatal Degeneration in the Cognitive Part of the Striatum in Parkinson Disease Is Associated With Frontomedial Hypometabolism
Ivayla Apostolova, Catharina Lange, Lars Frings, et al.
Neuroimage
|
June 30, 2006
A1 adenosine receptor PET using [18F]CPFPX: displacement studies in humans
Philipp T Meyer, David Elmenhorst, Andreas Matusch, et al.
Page
of 22
Search research articles
Search
Showing results (21-30 of 216) with videos related to
Sort By:
Page
of 22
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 12, 2012
Caffeine occupancy of human cerebral A1 adenosine receptors: in vivo quantification with 18F-CPFPX and PET
David Elmenhorst, Philipp T Meyer, Andreas Matusch, et al.
Nuklearmedizin. Nuclear Medicine
|
April 15, 2025
The Status of Neuroimaging with SPECT and PET in Germany: Results from the 1st Survey on Nuclear Neuroimaging in Germany in 2023
Ralph Buchert, Alexander Drzezga, Mathias Schreckenberger, et al.
Clinical Nuclear Medicine
|
May 27, 2022
Diffuse Bone Marrow Involvement of Multiple Myeloma on [ 18 F]PSMA-1007 PET/CT : Is There a Theranostic Potential?
Kerstin Michalski, Cordula A Jilg, Monika Engelhardt, et al.
Journal of Alzheimer'S Disease : JAD
|
May 17, 2021
DAT SPECT Predicts Survival in Patients Assessed for Differential Diagnosis of Dementia
Lars Frings, Franziska Henninger, Martin Treppner, et al.
Alzheimer'S Research & Therapy
|
January 10, 2023
More extensive hypometabolism and higher mortality risk in patients with right- than left-predominant neurodegeneration of the anterior temporal lobe
Lars Frings, Ganna Blazhenets, Raphael Binder, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 11, 2018
Amyloid imaging for differential diagnosis of dementia: incremental value compared to clinical diagnosis and [<sup>18</sup>F]FDG PET
Sabine Hellwig, Lars Frings, Tobias Bormann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 30, 2024
Reliable diagnosis of nigrostriatal degeneration by dopamine transporter SPECT despite drug interaction with venlafaxine or bupropion
Ivayla Apostolova, Sabine Hellwig, Amir Karimzadeh, et al.
Scientific Reports
|
August 28, 2024
Deformation-based morphometry applied to FDG PET data reveals hippocampal atrophy in Alzheimer's disease
Lars Frings, Ganna Blazhenets, Joachim Brumberg, et al.
Clinical Nuclear Medicine
|
December 27, 2019
Nigrostriatal Degeneration in the Cognitive Part of the Striatum in Parkinson Disease Is Associated With Frontomedial Hypometabolism
Ivayla Apostolova, Catharina Lange, Lars Frings, et al.
Neuroimage
|
June 30, 2006
A1 adenosine receptor PET using [18F]CPFPX: displacement studies in humans
Philipp T Meyer, David Elmenhorst, Andreas Matusch, et al.
Page
of 22